Let us pause and consider March 30. Not only is it National Doctor’s Day, but it has special importance for me. It’s my birthday, and this year marked a milestone. We don’t need to count the candles, but let’s just say there were a lot of them.
My husband, Neal, made it a day I will never forget, including a private tour of the Lowell Observatory in Flagstaff, Arizona.
The month of March gave the NeuroNetwork quite a few other reasons to celebrate – Women’s History Month, World Obesity Day, and St. Patrick Day’s, which our many Irish alumni helped us to commemorate boisterously.
On a more serious note, the month saw our laboratory honored with a Platinum rating, the highest possible, by the U-M Office of Sustainability. I would like to recognize our Green Team who were largely responsible, led by Jacquelin Kwentus, Dr. Claudia Figueroa-Romero, Crystal Pacut, and Diana Rigan.
We also had two important studies published. The first was in the Frontiers of Endocrinology on the high prevalence of neuropsychological complications among patients with diabetes. The second was in the Frontiers of Immunology, exploring our progress toward bringing the FDA-approved drug tofacitinib to clinical trial for ALS patients, who currently have very poor treatment options.
Now, I am off to the American Academy of Neurology annual meeting, the first time I will be at a conference in person since the pandemic. More on that next month.
Let’s all enjoy the start of spring and hope it brings some semblance of normalcy back to our lives.